4 new cases of COVID-19 out of 1,060 tested; CAR score 0.3

293

Four new cases of COVID-19 were identified out of 1,060 tests performed on Wednesday, March 17. Two (2) cases reported recent travel history and were identified in quarantine.

To date, there have been a total of 7,780 officially reported cases of COVID-19 with 134 deaths, 28 cases in active isolation, and 7,618 not in active isolation.

TODAY’S CAR SCORE

0.3

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following tables provide COVID-19 test results reported to the JIC on Thursday, March 18, and reflects results from Wednesday, March 17:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,780

4

22

CONFIRMED CASES:

7,570

4

22

PROBABLE CASES:

210

0

0

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

136,135

1,060

1.2%

MOLECULAR TESTS

126,284

1,052

1.3%

ANTIGEN TEST

9,851

8

0%

SEROLOGY TESTS

361

1

50%

 

CASE BREAKDOWN

STATUS

TOTAL

CURRENT ISOLATION LOCATION

TOTAL

COVID-19 Death

134

Hospital

5

Active Isolation

28

Home

9

Not In Isolation

7,618

Isolation Facility

6

Civilian

7,383

Military

8

Military Service Member

397

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

5

0

0

5

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

The following provides preliminary COVID-19 vaccinations reported to the JIC on Thursday, March 18, for vaccinations administered from December 17 to March 17:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Total Doses Administered

Individuals Fully Immunized

Pfizer-BioNTech

19,775

15,801*

35,576

15,801

Moderna

16,210**

14,170***

30,380

14,170

Johnson & Johnson Janssen

15****

15****

TOTALS:

35,985

29,971

65,971^

29,986

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one dose series.

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

65,971^

87,860^^

75.09%

21,889

^As of March 17, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states “After dilution, one vial contains 6 doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains 5 doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.

(JIC Release No. 606)

##